Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: Isolated cell-bound membrane vesicles (CBMVs) as a novel class of drug nanocarriers

Fig. 2

The cell-killing ability of isolated cell-bound membrane vesicles loaded with doxorubicin (Dox-CBMVs at the Dox concentration of 10 μg/mL; i.e. V–D in the graphs) detected by MTT assay. Three mouse cancer cell types (colon cancer CT26.WT cells, lung cancer LLC Lewis cells, and liver cancer Hepa1-6 cells), one human cancer cell types (liver cancer SMMC-7721 cells) and one human healthy cell type (HUVECs) were treated at 37 °C for 24 h. *, **, and *** represent p < 0.05, p < 0.01, and p < 0.001 compared with the PBS group or the group of CBMVs loaded without Dox (V in the graphs), respectively

Back to article page